Related Experiment Video
Updated: Jun 21, 2026
07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
[GST genes expression as prognostic factor in papillary thyroid cancer]
Antonio Jose Gonçalves1, Osmar Monte, Eliane Cristina Morari
1Departamento de Cirurgia, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, SP. dr.goncalves@uol.com.br
Revista Da Associacao Medica Brasileira (1992)
|July 25, 2009
Summary
The absence of GSTT1 and GSTM1 genes showed no correlation with the prognosis of papillary thyroid carcinoma, according to the AMES classification. This finding impacts understanding of thyroid cancer risk factors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer.
- The AMES classification is a prognostic tool used to assess PTC risk.
- Glutathione S-transferase (GST) enzymes, including GSTT1 and GSTM1, play roles in detoxification and cancer development.
Purpose:
- To investigate the association between the presence or absence of GSTT1 and GSTM1 genes and the prognosis of well-differentiated thyroid cancer.
- To determine if GST gene polymorphisms correlate with risk stratification using the AMES classification in PTC patients.
Summary:
- This study analyzed 66 patients with papillary thyroid carcinoma, categorizing them by AMES classification (high-risk vs. low-risk).
- The researchers examined the null genotype frequencies for GSTT1 and GSTM1 in both risk groups.
- Results indicated no significant relationship between the absence of GSTT1 and GSTM1 genes and the prognostic outcome as determined by the AMES classification.
Impact:
- The findings suggest that GSTT1 and GSTM1 gene status may not be a predictive biomarker for papillary thyroid carcinoma prognosis within the AMES risk stratification system.
- This research contributes to a deeper understanding of the molecular underpinnings of thyroid cancer and its progression.
- Further studies may explore other genetic factors or molecular pathways involved in PTC prognosis.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:11Reporter Genes
Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
Commonly used reporter...
Commonly used reporter...